Welcome to the Let the Money Talk podcast.
In this episode, Phillip Securities Research's head of research, Paul Chew, discusses the report on IX Biopharma Limited company updates. There is 4 positive catalyst to the share price.
Listen to this podcast to learn more about the latest corporate updates. Alternatively, visit www.stocksbnb.com for the full report.
